Trial no.:
|
PACTR202003487312437 |
Date of Approval:
|
17/03/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
dexamethasone dose as an adjuvant in supra clavicular block |
Official scientific title |
Lower effective dose of dexamethasone as an adjuvant to bupivacaine in supra-clavicular block: comparetive study. |
Brief summary describing the background
and objectives of the trial
|
The supraclavicular block is a regional anesthetic technique used as an alternative or adjuvant to general anesthesia or used for postoperative analgesia for upper limbs surgeries. dexamethasone is a one of most common additive drugs to local anaesthesia. ceiling dose of dexamethasone is questionable,In this clinical trial , we will study the ceiling dose of dexamethasone according to recent puplished meta –analysis 4 mg with sub ceiling dose 3mg as an adjuvant to bupivacaine in supra clavicular block, comparing their analgesic efficacy and possible side effects and complications. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
dexamethasone |
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
15/03/2020 |
Actual trial start date |
|
Anticipated date of last follow up |
30/09/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|